Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acrongenomics, Inc.
Acrongenomics, Inc. Announces Share Buyback Program
November 7th, 2008
Acrongenomics, Inc. (OTCBB:AGNM) is pleased to announce that its board of directors decided to proceed in a share buyback program. The Company currently has approximately 21 million shares diluted and outstanding, which are traded on the NASDAQ OTC Bulletin Board. The repurchase program will be conducted in compliance with Rule 10b-18 of the Securities Exchange Act of 1934 and will expire no later than October 31, 2009. "Today, in the middle of turbulent times and despite such situation, the Board of Directors hereby illustrate our strong confidence in the long-term growth of the Company," said Plato Tzouvalis, President of Acrongenomics. ...
Source: Health Business Week (2008-11-07)
|
